1 Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards
for research into small vessel disease and its contribution to ageing
and neurodegeneration. Lancet Neurol 2013;12:822–38.
2 Wardlaw JM, Smith C, Dichgans M. Small vessel disease:
mechanisms and clinical implications. Lancet Neurol
2019;18:684–96.
3 Chui H, dementia V. Vascular dementia, a new beginning: shifting
focus from clinical phenotype to ischemic brain injury. Neurol Clin
2000;18:951–78.
4 Tomimoto H. Subcortical vascular dementia. Neurosci Res
2011;71:193–9.
5 Pantoni L. Cerebral small vessel disease: from pathogenesis and
clinical characteristics to therapeutic challenges. Lancet Neurol
2010;9:689–701.
6 Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral
small vessel disease: a road map on key definitions and current
concepts. Int J Stroke 2016;11:6–18.
7 Furuta A, Ishii N, Nishihara Y, Horie A, et al. Medullary arteries in
aging and dementia. Stroke 1991;22:442–6.
8 Thanprasertsuk S, Martinez-Ramirez S, Pontes-Neto OM, et al.
Posterior white matter disease distribution as a predictor of amyloid
angiopathy. Neurology 2014;83:794–800.
9 Charidimou A, Jaunmuktane Z, Baron J-C, et al. White matter
perivascular spaces: an MRI marker in pathology-proven cerebral
amyloid angiopathy? Neurology 2014;82:57–62.
10 Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral
microbleeds: a guide to detection and interpretation. Lancet Neurol
2009;8:165–74.
11 Linn J, Halpin A, Demaerel P, et al. Prevalence of superficial
siderosis in patients with cerebral amyloid angiopathy. Neurology
2010;74:1346–50.
12 Kövari E, Herrmann FR, Gold G, et al. Association of cortical
microinfarcts and cerebral small vessel pathology in the ageing brain.
Neuropathol Appl Neurobiol 2017;43:505–13.
13 Ishikawa H, Ii Y, Shindo A, et al. Cortical microinfarcts detected by
3-tesla magnetic resonance imaging. Stroke 2020;51:1010–3.
14 Klarenbeek P, van Oostenbrugge RJ, Rouhl RPW, et al. Ambulatory
blood pressure in patients with lacunar stroke: association with total
MRI burden of cerebral small vessel disease. Stroke 2013;44:2995–9.
15 Staals J, Makin SDJ, Doubal FN, et al. Stroke subtype, vascular risk
factors, and total MRI brain small-vessel disease burden. Neurology
2014;83:1228–34.
16 Huijts M, Duits A, van Oostenbrugge RJ, et al. Accumulation of
MRI markers of cerebral small vessel disease is associated with
decreased cognitive function. A study in first-ever lacunar stroke and
hypertensive patients. Front Aging Neurosci 2013;5:72.
17 Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total magnetic
resonance imaging burden of small vessel disease in cerebral
amyloid angiopathy: an imaging-pathologic study of concept
validation. JAMA Neurol 2016;73:994–1001.
18 Boulouis G, Charidimou A, Jessel MJ, et al. Small vessel disease
burden in cerebral amyloid angiopathy without symptomatic
hemorrhage. Neurology 2017;88:878–84.
19 Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild
cognitive impairment due to Alzheimer's disease: recommendations
from the National Institute on Aging-Alzheimer's association
workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement 2011;7:270–9.
20 McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of
dementia due to Alzheimer’s disease: Recommendations from the
National Institute on Aging-Alzheimer’s Association workgroups
BMJ Open: first published as 10.1136/bmjopen-2020-042550 on 8 April 2021. Downloaded from http://bmjopen.bmj.com/ on April 11, 2021 at Mie Daigaku Toshokan. Protected by copyright.
Open access
21
22
23
24
25
26
27
28
29
10
on diagnostic guidelines for Alzheimer’s disease. Alzheimer's &
Dementia 2011;7:263–9.
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to
cognitive impairment and dementia: a statement for healthcare
professionals from the American heart association/american stroke
association. Stroke 2011;42:2672–713.
Mori E, Mitani Y, Yamadori A. Usefulness of a Japanese version
of the Mini-Mental state test in neurological patients. Jpn J
Neuropsychol 1985;1:82–90.
Raven JC. Coloured progressive matrices, sets a, AB, B. London:
H.K. Lewis, 1962.
Wilson B, Cockburn J, Baddeley A, et al. The development and
validation of a test battery for detecting and monitoring everyday
memory problems. J Clin Exp Neuropsychol 1989;11:855–70.
Satoh M, Mori C, Matsuda K, et al. Improved Necker cube drawingbased assessment battery for constructional apraxia: the Mie
Constructional apraxia scale (MCAS). Dement Geriatr Cogn Dis Extra
2016;6:424–36.
Abe M, Suzuki K, Okada K, et al. [Normative data on tests for frontal
lobe functions: Trail Making Test, Verbal fluency, Wisconsin Card
Sorting Test (Keio version)]. No To Shinkei 2004;56:567–74.
Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the
staging of dementia. Br J Psychiatry 1982;140:566–72.
Ii Y, Maeda M, Ishikawa H, et al. Cortical microinfarcts in
patients with multiple lobar microbleeds on 3 T MRI. J Neurol
2019;266:1887–96.
Tabei K-I, Kida H, Hosoya T, et al. Prediction of cognitive decline
from white matter hyperintensity and single-photon emission
computed tomography in Alzheimer's disease. Front Neurol
2017;8:408–18.
30 Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection
of FLAIR-hyperintense white-matter lesions in multiple sclerosis.
Neuroimage 2012;59:3774–83.
31 Gregoire SM, Scheffler G, Jäger HR, et al. Strictly lobar microbleeds
are associated with executive impairment in patients with ischemic
stroke or transient ischemic attack. Stroke 2013;44:1267–72.
32 Vernooij MW, Ikram MA, Hofman A, et al. Superficial siderosis in the
general population. Neurology 2009;73:202–5.
33 Kövari E, Gold G, Herrmann FR, et al. Cortical microinfarcts and
demyelination affect cognition in cases at high risk for dementia.
Neurology 2007;68:927–31.
34 van der Flier WM, van Straaten ECW, Barkhof F, et al. Small vessel
disease and general cognitive function in nondisabled elderly: the
LADIS study. Stroke 2005;36:2116–20.
35 McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of
dementia due to Alzheimer's disease: recommendations from the
National Institute on Aging-Alzheimer's association workgroups on
diagnostic guidelines for Alzheimer's disease. Alzheimers Dement
2011;7:263–9.
36 Bennett DA, Schneider JA, Bienias JL, et al. Mild cognitive
impairment is related to Alzheimer disease pathology and cerebral
infarctions. Neurology 2005;64:834–41.
37 Yakushiji Y, Wilson D, Ambler G. Distribution of cerebral microbleeds
in the East and West-Individual participant meta-analysis. Neurology
2019;93:e1086–97.
38 Arvanitakis Z, Capuano AW, Leurgans SE, et al. The relationship
of cerebral vessel pathology to brain microinfarcts. Brain Pathol
2017;27:77–85.
Matsuda K, et al. BMJ Open 2021;11:e042550. doi:10.1136/bmjopen-2020-042550
BMJ Open: first published as 10.1136/bmjopen-2020-042550 on 8 April 2021. Downloaded from http://bmjopen.bmj.com/ on April 11, 2021 at Mie Daigaku Toshokan. Protected by copyright.
Open access
...
論文の公開元へ
